Top Tech Companies (2,065)
Don't see your company?
Create a company profile
Nanobot Medical Animation delivers digital solutions for the pharmaceutical, biotech and medical device industries.
Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells. We are tenacious and will keep pushing the known boundaries to make breakthroughs where others have not.
ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. It is also a global market leader in advanced contrast imaging systems for cardiovascular angiography and radiology imaging. Through these products, ACIST is demonstrating its commitment to bringing unique and innovative technologies that simplify cardiovascular procedures and empower clinicians to treat patients with superior care. As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with broad expertise in cath lab technology and a dedication to continuous advancement. Headquartered in Eden Prairie, Minnesota, USA, ACIST has worldwide presence with over 300 direct employees and facilities in Silicon Valley, Maastricht, Shanghai and Tokyo.
Kernel creates the interfaces and insights necessary to unlock the greatest scientific unknown: the inner workings of the human brain and mind. Kernel is a full-stack neurotech company founded in 2016 with the mandate to do something that will change the world. Kernel is leveraging the best non-invasive brain scanning techniques to create next-generation technologies that dramatically expand the accuracy, frequency, and environments in which cognitive activity can be monitored. Our proprietary technology is designed in-house, and built from the ground up, with neuroscientists, physicists, and engineers controlling every step of the process, from chip design to optics; control software to machine learning; experimental design to analysis. Most noninvasive methods for recording brain signals measure electromagnetic fields generated by groups of neurons, or detect small changes in blood oxygenation (which correlate well to nearby neural activity). But existing technology in both of these technologies are rife with drawbacks, limitations or shortcomings. Kernel is building the next generation of both of these modalities, leveraging the strengths of OP-MEG (optically-pumped magnetoencephalography) and TD-fNIRS (time-domain functional near-infrared spectroscopy) into products that offer the following benefits: • High-quality neural signal • Full-head coverage • Scalability • Relatively low cost • Natural environments, stimuli, and interactions • Freedom of user motion
Transforming lives through advancements in biomaterials.
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers.
ACON Laboratories is an international diagnostic and medical device company with our corporate headquarters in San Diego, California USA. For more than 15 years, ACON has led the way in making high quality diagnostic and medical devices more affordable to people all around the world. The ACON name is well known in over 130 countries. Headquartered in San Diego, California, the US office is the center of strategic management, administration, business development, innovative research and development. Our state of the art manufacturing facility is ISO 13485:2003 certified, FDA registered and has been inspected by US FDA. Our current product lines include Diabetes Care, Clinical Chemistry (including Urinalysis and Point of Care Tests) and Immunoassay EIA/ELISA. We also have a number of new products in the pipeline for introduction in the future.
Biolytx Pharmaceuticals developing a drug focused on promoting wound healing and killing antibiotic resistant bacteria.
Here at CRISPR QC, we empower scientists using CRISPR to solve the world’s great challenges by providing the key cornerstones of information and insight fundamental to realizing the full potential of CRISPR.
Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earli's technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. It's called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by Andreessen Horowitz's Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.
Vistim Labs is medtech diagnostic helping pharma detect, treat, and track neurological disorders. We offer a brain scan for high precision measurement of cognition function and treatment efficacy. Our mission is to accelerate access to care by improving clinical decision making ability with our proprietary artificial intelligence platform. Our biomarkers of cognitive decline are useful for predicting symptomatic onset of disease and for measuring efficacy of treatment for emerging interventions. In this way, patients receive the most effective treatments available and quality of life is protected.
Advanced Cancer Therapeutics, LLC engages in the discovery, development, manufacture, and commercialization of cancer therapeutics.
Prominex is focused on the development and manufacture of molecular diagnostic assays for Point-of-Care (POC) infectious disease testing.
EyeKor is a network of established reading centers and clinical trial experts.
TriMetis is a preclinical services company that provides biospecimen procurement and specialty laboratory and consultation services.
Gatehouse Bio is developing therapeutics that correct the effects of disease-driving mutations in small RNA genes. We believe there is an RNA code that can treat every disease. Our mission is to find that code and use it to develop effective therapeutics. Our platform is the first to use AI to discover small RNA mutations and design oligonucleotides that crack a disease’s code. Our pipeline and partnerships are focused on developing drugs for therapeutic areas with known heterogeneity such as fibrosis, inflammation and neurodegeneration. With every single code we break, we unlock the potential to improve the lives of many.
DNA Polymerase Technology develops technology for detecting, analyzing and manipulating genes.
Dompé is an Italian bio-pharmaceutical company that focuses on innovation, where a long tradition in the field of personal wellness goes hand in hand with a commitment to research and development to meet hitherto unsatisfied therapeutic needs. Established in 1940 in Milan, Dompé continues to have its headquarters in this city. In Italy, it also has offices in L’Aquila, with an industrial and biotech research hub, and in Naples, where the Company has an R&D division. Dompé also has branches in the United States (Boston and San Francisco), in Albania (Tirana) and China (Shanghai). Primary Care Dompé, with its products offered at over 10,000 pharmacies in Italy, is engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personal hygiene. The therapeutic areas include cardiovascular, gastrointestinal, paediatrics, neurology, urology, ophthalmic, stomatology and respiratory. Dompé currently markets 50 million medication packages in roughly 40 countries around the world. Biotech and rare diseases The Biotech unit is a manifestation of Dompé commitment to meeting unsatisfied patient needs all around the world. The Biotech Unit focuses specifically on the rare diseases field, such as ophthalmology, for instance, an area in which the company has developed and marketed the first ophthalmic product based on rhNGF (the molecule discovered by Nobel Prize winner Rita Levi Montalcini) for patients suffering from neurotrophic keratitis. For more information on Dompé visit www.dompe.com To explore career opportunities at Dompé visit http://www.dompe.com/Careers-en/
Valitor, Inc. is a biotechnology company founded to develop advanced, protein-based drugs. Using our core technology, we can modify existing biological therapies to achieve substantial control over their pharmacological properties. Our mission is to develop a new generation of biologic therapies that will reduce the costs associated with effective treatment of these diseases. We also aim to improve the patients’ quality of life by reducing the required frequency of therapeutic administration. We have initiated a pipeline of drug products that will be used to treat a variety of diseases currently imposing a significant financial burden on the nation’s healthcare system. Valitor is currently hiring! Visit: http://www.valitorbio.com/careers.html for more details.
Cellics Therapeutics, Inc. is a biotech company using the innovative Cellular Nanosponge platform technology to create treatment and vaccines for hard-to-treat infectious and inflammatory diseases. Cellics has a rich pipeline and its lead indication is ready to move into clinical phase 1b/2a. Cellics team is currently expanding quickly and we are looking for innovative and goal-driven team members to join the team.
